Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors-Reference-Cited by-同舟云学术

Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors

Published:2022-02 Issue: Volume:56 Page:116616
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Tsuji Kohei,Kobayakawa Takuya,Konno Kiju,Masuda Ami,Takahashi Kohei,Ohashi Nami,Yoshimura Kazuhisa,Kuwata Takeo,Matsushita Shuzo,Harada Shigeyoshi,Tamamura Hirokazu

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference54 articles.

1. Peptide-derived mid-sized anti-HIV agents;Ohashi,2017

2. In: Mid-size drugs based on peptides and peptidomimetics: A new drug category;Tamamura,2018

3. Recent progress in the development of small-molecule therapeutics to treat HIV/AIDS;Maeda;Curr Top Med Chem,2019

4. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro;Mitsuya;Proc Natl Acad Sci U S A,1985

5. Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV;Ghosh;Bioorg Med Chem,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Protein–Protein Interaction Inhibitors;Journal of Medicinal Chemistry;2024-02-23

2. Strategies to overcome HIV drug resistance-current and future perspectives;Frontiers in Microbiology;2023-02-16

3. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates;Journal of Virology;2023-01-31

4. Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C;Virology;2023-01

5. Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors;Bioorganic & Medicinal Chemistry;2022-12